Given the context of clinical medicine, you are likely interested in the , particularly in patients with severe COVID-19 pneumonia or cytokine release syndrome (CRS).

Below is a structured, concise academic paper on this topic.

Tocilizumab is administered via intravenous infusion or subcutaneous injection, depending on the formulation. The dosage schedule varies based on the condition being treated and the patient's weight.

Strengths

The post provided here relates to Tocilizumab based on my general knowledge; If "Tecilizumab" or similar drug names & "ABG" (arterial blood gas - a medical test) are what you are trying to find information on a different post may be more suitable.